These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 26092074)

  • 1. Usefulness of the Visceral Adiposity Index in Different Populations.
    Peng TC; Chen WL; Kao TW
    Am J Med; 2015 Jul; 128(7):e25-6. PubMed ID: 26092074
    [No Abstract]   [Full Text] [Related]  

  • 2. The Reply.
    Salazar MR; Reaven GM
    Am J Med; 2015 Jul; 128(7):e27. PubMed ID: 26092075
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of cardiometabolic risk: visceral adiposity index versus triglyceride/HDL cholesterol ratio.
    Salazar MR; Carbajal HA; Espeche WG; Aizpurúa M; Maciel PM; Reaven GM
    Am J Med; 2014 Feb; 127(2):152-7. PubMed ID: 24462013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Handgrip strength attenuates the adverse effects of overweight on cardiometabolic risk factors among collegiate students but not in individuals with higher fat levels.
    Garcia-Hermoso A; Tordecilla-Sanders A; Correa-Bautista JE; Peterson MD; Izquierdo M; Prieto-Benavides D; Sandoval-Cuellar C; González-Ruíz K; Ramírez-Vélez R
    Sci Rep; 2019 May; 9(1):6986. PubMed ID: 31061449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical indications and proper use of Visceral Adiposity Index.
    Amato MC; Giordano C
    Nutr Metab Cardiovasc Dis; 2013 Aug; 23(8):e31-2. PubMed ID: 23786826
    [No Abstract]   [Full Text] [Related]  

  • 6. [Visceral fat and metabolic syndrome: more than a simple association].
    Ribeiro Filho FF; Mariosa LS; Ferreira SR; Zanella MT
    Arq Bras Endocrinol Metabol; 2006 Apr; 50(2):230-8. PubMed ID: 16767289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular disease under the influence of excess visceral fat.
    Després JP
    Crit Pathw Cardiol; 2007 Jun; 6(2):51-9. PubMed ID: 17667865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of rimonabant on the high-triglyceride/ low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat: the ADAGIO-Lipids trial.
    Després JP; Ross R; Boka G; Alméras N; Lemieux I;
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):416-23. PubMed ID: 19112166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolic syndrome and visceral fat in women with cardiovascular risk factor].
    Soto Rodríguez A; García Soidán JL; Arias Gómez MJ; Leirós Rodríguez R; Del Álamo Alonso A; Pérez Fernández MR
    Nutr Hosp; 2017 Jul; 34(4):863-868. PubMed ID: 29095010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral and not subcutaneous abdominal adiposity reduction drives the benefits of a 1-year lifestyle modification program.
    Borel AL; Nazare JA; Smith J; Alméras N; Tremblay A; Bergeron J; Poirier P; Després JP
    Obesity (Silver Spring); 2012 Jun; 20(6):1223-33. PubMed ID: 22262155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new look at the genetic and environmental coherence of metabolic syndrome components.
    Panizzon MS; Hauger RL; Sailors M; Lyons MJ; Jacobson KC; Murray McKenzie R; Rana B; Vasilopoulos T; Vuoksimaa E; Xian H; Kremen WS; Franz CE
    Obesity (Silver Spring); 2015 Dec; 23(12):2499-507. PubMed ID: 26524476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visceral adiposity index as an indicator of cardiometabolic risk in patients treated for craniopharyngioma.
    Ferraù F; Spagnolo F; Cotta OR; Cannavò L; Alibrandi A; Russo GT; Aversa T; Trimarchi F; Cannavò S
    Endocrine; 2017 Nov; 58(2):295-302. PubMed ID: 27981514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Three Adiposity Indexes and Cutoff Values to Predict Metabolic Syndrome Among University Students.
    Correa-Bautista JE; González-Ruíz K; Vivas A; Triana-Reina HR; Martínez-Torres J; Prieto-Benavides DH; Carrillo HA; Ramos-Sepúlveda JA; Afanador-Rodríguez MI; Villa-González E; García-Hermoso A; Ramírez-Vélez R
    Metab Syndr Relat Disord; 2017 Sep; 15(7):363-370. PubMed ID: 28570830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ectopic visceral fat: a clinical and molecular perspective on the cardiometabolic risk.
    Mathieu P; Boulanger MC; Després JP
    Rev Endocr Metab Disord; 2014 Dec; 15(4):289-98. PubMed ID: 25326657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.
    Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positively increased visceral adiposity index in hyperuricemia free of metabolic syndrome.
    Gu D; Ding Y; Zhao Y; Miao S; Qu Q
    Lipids Health Dis; 2018 May; 17(1):101. PubMed ID: 29734946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors.
    Quijada Z; Paoli M; Zerpa Y; Camacho N; Cichetti R; Villarroel V; Arata-Bellabarba G; Lanes R
    Pediatr Diabetes; 2008 Oct; 9(5):464-71. PubMed ID: 18507788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity, ultrasound indexes of fat depots and lipid goal attainment in patients with high and very high cardiovascular risk: A novel approach towards better risk reduction.
    Haberka M; Okopień B; Gąsior Z
    Nutr Metab Cardiovasc Dis; 2016 Feb; 26(2):123-33. PubMed ID: 26830392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver fat, visceral fat and metabolic syndrome in patients with severe obesity.
    Kawada T
    Int J Surg; 2015 Oct; 22():153. PubMed ID: 26343975
    [No Abstract]   [Full Text] [Related]  

  • 20. Adipose tissue and metabolic alterations: regional differences in fat cell size and number matter, but differently: a cross-sectional study.
    Rydén M; Andersson DP; Bergström IB; Arner P
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E1870-6. PubMed ID: 24937536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.